English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

The TCRβ Enhancer Is Dispensble for the Expression of Rearranged TCRβ Genes in Thymic DN2/DN3 Populations but Not at Later Stages

MPS-Authors
/persons/resource/persons81833

Busse,  Christian E.
Max-Planck Research Group Molecular Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons191170

Krotkova,  Anna
Emeritus Group: Cellular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

/persons/resource/persons191039

Eichmann,  Klaus
Department of Cellular and Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Busse, C. E., Krotkova, A., & Eichmann, K. (2005). The TCRβ Enhancer Is Dispensble for the Expression of Rearranged TCRβ Genes in Thymic DN2/DN3 Populations but Not at Later Stages. The Journal of Immunology, 175, 3067-3074.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002B-933D-3
Abstract
The Eβ enhancer has been shown to be dispensable for germline transcription of nonrearranged TCRβ segments but appears to be required for TCRβ V to DJ rearrangement. Eβ dependency of the subsequent expression of VDJ-rearranged TCRβ genes in thymic subpopulations has so far not been analyzed. We generated transgenic mice, using a Vβ8.2Dβ1Jβ1.3-rearranged TCRβ bacterial artificial chromosome, which lacked Eβ, and monitored transgene expression by flow cytometry using Vβ-specific mAbs and an IRES-eGFP reporter. Transgene expression was found in double negative (DN)2 and DN3 but not at later stages of thymopoesis. There was no toxicity associated with the transgene given that apoptosis in DN3, DN4 was not increased, and the number of DN4 cells generated from DN3 cells in reaggregate thymic organ cultures was not diminished. The transgenic TCRβ gave rise to a pre-TCR, as suggested by its ability to suppress endogenous TCRβ rearrangement, to facilitate β-selection on a TCRβ-deficient background and to inhibit γδ T cell lineage development. The results suggest that the Vβ8.2 promoter is sufficient to drive expression of rearranged TCRβ VDJ genes Eβ independently in DN2/DN3 but not at later stages.